Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

被引：25

作者：

Shields, Adrian M. ^{[1
]}

Anantharachagan, Ariharan ^{[2
]}

Arumugakani, Gururaj ^{[3
]}

Baker, Kenneth ^{[4
,5
]}

Bahal, Sameer ^{[6
]}

Baxendale, Helen ^{[7
]}

Bermingham, William ^{[8
]}

Bhole, Malini ^{[9
]}

Boules, Evon ^{[10
]}

Bright, Philip ^{[11
]}

Chopra, Charu ^{[12
]}

Cliffe, Lucy ^{[13
]}

Cleave, Betsy ^{[13
]}

Dempster, John ^{[14
]}

Devlin, Lisa ^{[15
]}

Dhalla, Fatima ^{[16
]}

Diwakar, Lavanya ^{[17
]}

Drewe, Elizabeth ^{[13
]}

Duncan, Christopher ^{[18
]}

Dziadzio, Magdalena ^{[19
]}

Elcombe, Suzanne ^{[20
]}

Elkhalifa, Shuayb ^{[21
]}

Gennery, Andrew ^{[22
,23
]}

Ghanta, Harichandrana ^{[24
]}

Goddard, Sarah ^{[17
]}

Grigoriadou, Sofia ^{[25
]}

Hackett, Scott ^{[26
]}

Hayman, Grant ^{[27
]}

Herriot, Richard ^{[28
]}

Herwadkar, Archana ^{[21
]}

Huissoon, Aarnoud ^{[8
]}

Jain, Rashmi ^{[16
]}

Jolles, Stephen ^{[29
]}

Johnston, Sarah ^{[11
]}

Khan, Sujoy ^{[30
]}

Laffan, James ^{[27
]}

Lane, Peter ^{[1
]}

Leeman, Lucy ^{[31
]}

Lowe, David M. ^{[6
,32
]}

Mahabir, Shanti ^{[33
]}

Mac Lochlainn, Dylan James ^{[16
]}

McDermott, Elizabeth ^{[13
]}

Misbah, Siraj ^{[16
]}

Moghaddas, Fiona ^{[11
]}

Morsi, Hadeil ^{[16
]}

Murng, Sai ^{[27
]}

Noorani, Sadia ^{[34
]}

O'Brien, Rachael ^{[35
]}

Patel, Smita ^{[16
]}

Price, Arthur ^{[33
]}

机构：

[1] Univ Birmingham, Inst Immunol & Immunotherapy, Clin Immunol Serv, Birmingham, W Midlands, England

[2] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England

[3] Leeds Teaching Hosp NHS Trust, Dept Clin Immunol & Allergy, St James Univ Hosp, Leeds, W Yorkshire, England

[4] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[5] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England

[6] Royal Free London NHS Fdn Trust, Dept Immunol, London, England

[7] Royal Papworth NHS Fdn Trust, Cambridge, England

[8] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[9] Dudley Grp NHS Fdn Trust, Birmingham, W Midlands, England

[10] Sheffield Teaching Hosp NHS Fdn Trust, Clin Immunol & Allergy Dept, Sheffield, S Yorkshire, England

[11] North Bristol NHS Trust, Clin Immunol, Bristol, Avon, England

[12] Royal Infirm Edinburgh NHS Trust, Dept Haematol & Immunol, NHS Lothian, Edinburgh, Midlothian, Scotland

[13] Nottingham Univ Hosp NHS Trust, Clin Immunol & Allergy Dept, Nottingham, England

[14] Univ Coll London Hosp, Specialist Allergy & Clin Immunol, London, England

[15] Royal Hosp, Reg Immunol Serv, Belfast, Antrim, North Ireland

[16] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Immunol, Oxford, England

[17] Royal Stoke Hosp, Dept Immunol, Stoke On Trent, Staffs, England

[18] Newcastle Univ, Translat & Clin Res Inst, Immun & Inflammat Theme, Newcastle Upon Tyne, Tyne & Wear, England

[19] UCL, Ear Inst, London, England

[20] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Reg Dept Clin Immunol & Allergy, Newcastle Upon Tyne, Tyne & Wear, England

[21] Salford Royal NHS Fdn Trust, Immunol Dept, Manchester, Lancs, England

[22] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England

[23] Great North Children S Hosp, Paediat Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England

[24] Univ Southampton, Univ Hosp Southampton NHS Trust, Dept Allergy & Clin Immunol, Southampton, Hants, England

[25] Barts Hlth NHS Trust, Immunol Dept, Royal London Hosp, London, England

[26] Univ Hosp Birmingham, Paediat Immunol Dept, Birmingham, W Midlands, England

[27] Epsom & St Helier Univ Hosp NHS Trust, Clin Immunol Serv, South West London Immunodeficiency Ctr, London, England

[28] Aberdeen Royal Infirm, Immunol Dept, Aberdeen, Scotland

[29] Univ Hosp Wales, Immunodeficiency Ctr Wales, Heath Pk, Cardiff, Wales

[30] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England

[31] Univ Hosp Plymouth NHS Trust, Plymouth, Devon, England

[32] UCL, Inst Immun & Transplantat, London, England

[33] Leicester Royal Infirm, Clin Immunol & Allergy Dept, Leicester, Leics, England

[34] Sandwell & West Birmingham Hosp NHS Trust, Clin Immunol Dept, Birmingham, W Midlands, England

[35] Frimley Pk Hosp, Dept Clin Immunol, Frimley, Surrey, England

[36] NHS Greater Glasgow & Clyde, Clin Immunol Serv, Glasgow, Lanark, Scotland

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2022年 / 209卷 / 03期

关键词：

COVID-19; SARS-CoV-2; hypogammaglobulinemia; inborn errors of immunity; primary immunodeficiencies; secondary immunodeficiencies; lymphopenia; COVID-19; IMMUNITY;

D O I：

10.1093/cei/uxac008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In March 2020, the United Kingdom Primary Immunodeficiency Network (UKPIN) established a registry of cases to collate the outcomes of individuals with PID and SID following SARS-CoV-2 infection and treatment. A total of 310 cases of SARS-CoV-2 infection in individuals with PID or SID have now been reported in the UK. The overall mortality within the cohort was 17.7% (n = 55/310). Individuals with CVID demonstrated an infection fatality rate (IFR) of 18.3% (n = 17/93), individuals with PID receiving IgRT had an IFR of 16.3% (n = 26/159) and individuals with SID, an IFR of 27.2% (n = 25/92). Individuals with PID and SID had higher inpatient mortality and died at a younger age than the general population. Increasing age, low pre-SARS-CoV-2 infection lymphocyte count and the presence of common co-morbidities increased the risk of mortality in PID. Access to specific COVID-19 treatments in this cohort was limited: only 22.9% (n = 33/144) of patients admitted to the hospital received dexamethasone, remdesivir, an anti-SARS-CoV-2 antibody-based therapeutic (e.g. REGN-COV2 or convalescent plasma) or tocilizumab as a monotherapy or in combination. Dexamethasone, remdesivir, and anti-SARS-CoV-2 antibody-based therapeutics appeared efficacious in PID and SID. Compared to the general population, individuals with PID or SID are at high risk of mortality following SARS-CoV-2 infection. Increasing age, low baseline lymphocyte count, and the presence of co-morbidities are additional risk factors for poor outcome in this cohort. Individuals with immunodeficiency are at increased risk of severe infection. This study looks at outcomes following SARS-CoV-2 infection in 310 patients with primary or secondary immunodeficiency in the United Kingdom and finds significantly elevated mortality in both cohorts compared to the general population. Increasing age, pre-existing lymphopenia and other co-morbidities are identified as additional risk factors for death from COVID-19 in this cohort.

引用

页码：247 / 258

页数：12

共 28 条

[1] Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, Sarah
Chevrier, Stephane
Cervia, Carlo
Zurbuchen, Yves
Raeber, Miro E.
Yang, Liliane
Sivapatham, Sujana
Jacobs, Andrea
Baechli, Esther
Rudiger, Alain
Stussi-Helbling, Melina
Huber, Lars C.
Schaer, Dominik J.
Bodenmiller, Bernd
Boyman, Onur
Nilsson, Jakob
[J]. ALLERGY, 2021, 76 (09) : 2866 - 2881
[2] LETTER TO THE EDITOR
Al Yazidi, Laila S.
Al Rawahi, Hatem
Al Busaidi, Ibrahim
Al Tamemi, Salem
[J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (04) : 594 - 594
[3] COVID-19 as a trigger of acute attacks in people with hereditary angioedema
Belbezier, Aude
Arnaud, Melanie
Boccon-Gibod, Isabelle
Pelletier, Fabien
McAvoy, Chloe
Gobert, Delphine
Fain, Olivier
Du-Thanh, Aurelie
Launay, David
Lupo, Julien
Bouillet, Laurence
[J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (07) : 947 - 950
[4] Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study
Bennett, Kathleen E.
Mullooly, Maeve
O'Loughlin, Mark
Fitzgerald, Margaret
O'Donnell, Joan
O'Connor, Lois
Oza, Ajay
Cuddihy, John
[J]. LANCET REGIONAL HEALTH-EUROPE, 2021, 5
[5] Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned
Bucciol, Giorgia
Tangye, Stuart G.
Meyts, Isabelle
[J]. CURRENT OPINION IN PEDIATRICS, 2021, 33 (06) : 648 - 656
[6] Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Buckland, Matthew S.
Galloway, James B.
Fhogartaigh, Caoimhe Nic
Meredith, Luke
Provine, Nicholas M.
Bloor, Stuart
Ogbe, Ane
Zelek, Wioleta M.
Smielewska, Anna
Yakovleva, Anna
Mann, Tiffeney
Bergamaschi, Laura
Turner, Lorinda
Mescia, Frederica
Toonen, Erik J. M.
Hackstein, Carl-Philipp
Akther, Hossain Delowar
Vieira, Vinicius Adriano
Ceron-Gutierrez, Lourdes
Periselneris, Jimstan
Kiani-Alikhan, Sorena
Grigoriadou, Sofia
Vaghela, Devan
Lear, Sara E.
Torok, M. Estee
Hamilton, William L.
Stockton, Joanne
Quick, Josh
Nelson, Peter
Hunter, Michael
Coulter, Tanya I.
Devlin, Lisa
Bradley, John R.
Smith, Kenneth G. C.
Ouwehand, Willem H.
Estcourt, Lise
Harvala, Heli
Roberts, David J.
Wilkinson, Ian B.
Screaton, Nick
Loman, Nicholas
Doffinger, Rainer
Lyons, Paul A.
Morgan, B. Paul
Goodfellow, Ian G.
Klenerman, Paul
Lehner, Paul J.
Matheson, Nicholas J.
Thaventhiran, James E. D.
[J]. NATURE COMMUNICATIONS, 2020, 11 (01)
[7] Immunocompromised children and young people are at no increased risk of severe COVID-19
Chappell, H.
Patel, R.
Driessens, C.
Tarr, A. W.
Irving, W. L.
Tighe, P. J.
Jackson, H. J.
Harvey-Cowlishaw, T.
Mills, L.
Shaunak, M.
Gbesemete, D.
Leahy, A.
Lucas, J. S.
Faust, S. N.
de Graaf, H.
[J]. JOURNAL OF INFECTION, 2022, 84 (01) : 31 - 39
[8] SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Chen, Peter
Nirula, Ajay
Heller, Barry
Gottlieb, Robert L.
Boscia, Joseph
Morris, Jason
Huhn, Gregory
Cardona, Jose
Mocherla, Bharat
Stosor, Valentina
Shawa, Imad
Adams, Andrew C.
Van Naarden, Jacob
Custer, Kenneth L.
Shen, Lei
Durante, Michael
Oakley, Gerard
Schade, Andrew E.
Sabo, Janelle
Patel, Dipak R.
Klekotka, Paul
Skovronsky, Daniel M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) : 229 - 237
[9] Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
Delavari, Samaneh
Abolhassani, Hassan
Abolnezhadian, Farhad
Babaha, Fateme
Iranparast, Sara
Ahanchian, Hamid
Moazzen, Nasrin
Nabavi, Mohammad
Arshi, Saba
Fallahpour, Morteza
Bemanian, Mohammad Hassan
Shokri, Sima
Momen, Tooba
Sadeghi-Shabestari, Mahnaz
Molatefi, Rasol
Shirkani, Afshin
Vosughimotlagh, Ahmad
Safarirad, Molood
Sharifzadeh, Meisam
Pashangzadeh, Salar
Salami, Fereshte
Shirmast, Paniz
Rezaei, Arezou
Shad, Tannaz Moeini
Mohraz, Minoo
Rezaei, Nima
Hammarstrom, Lennart
Yazdani, Reza
Aghamohamamdi, Asghar
[J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (02) : 345 - 355
[10] Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Docherty, Annemarie B.
Harrison, Ewen M.
Green, Christopher A.
Hardwick, Hayley E.
Pius, Riinu
Norman, Lisa
Holden, Karl A.
Read, Jonathan M.
Dondelinger, Frank
Carson, Gail
Merson, Laura
Lee, James
Plotkin, Daniel
Sigfrid, Louise
Halpin, Sophie
Jackson, Clare
Gamble, Carrol
Horby, Peter W.
Nguyen-Van-Tam, Jonathan S.
Ho, Antonia
Russell, Clark D.
Dunning, Jake
Openshaw, Peter Jm
Baillie, J. Kenneth
Semple, Malcolm G.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369

← 1 2 3 →